A recent study from Tsukasa et al. [95] showed an interesting connection between CD133, a known PaCSC marker, and the activation of EMT through the miR-30 family in the pancreatic cancer cell line Capan-1M9. This evidence concerns the gene PROM1 and pancreatic neoplasm.